Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Diabetes Care
|
October 3, 2007
Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study
Märit Wallander, Klas Malmberg, Anna Norhammar, et al.
Heart (British Cardiac Society)
|
January 24, 2007
Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission
Anna Norhammar, Johan Lindbäck, Lars Rydén, et al.
European Journal of Preventive Cardiology
|
July 14, 2026
Obesity and Cardiovascular Outcomes After Myocardial Infarction - a nationwide SWEDEHEART analysis by diabetes status
Viveca Ritsinger, Bo Lagerqvist, Mattias Ekström, et al.
European Journal of Preventive Cardiology
|
February 6, 2020
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry
Viveca Ritsinger, Thomas Nyström, Nawsad Saleh, et al.
Cardiovascular Diabetology
|
August 7, 2024
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Viveca Ritsinger, Kamila Avander, Bo Lagerqvist, et al.
Journal of Periodontology
|
March 28, 2022
Association of peptidoglycan recognition protein 1 to post-myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study
Nilminie Rathnayake, Anders Gustafsson, Timo Sorsa, et al.
Diabetes & Vascular Disease Research
|
November 24, 2020
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
Viveca Ritsinger, Bo Lagerqvist, Pia Lundman, et al.
European Journal of Preventive Cardiology
|
May 17, 2022
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study
Stelios Karayiannides, Anna Norhammar, Lena Landstedt-Hallin, et al.
European Heart Journal
|
December 25, 2007
The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial
Linda G Mellbin, Klas Malmberg, Anna Norhammar, et al.
The Lancet. Diabetes & Endocrinology
|
May 17, 2014
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
Viveca Ritsinger, Klas Malmberg, Anton Mårtensson, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Diabetes Care
|
October 3, 2007
Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study
Märit Wallander, Klas Malmberg, Anna Norhammar, et al.
Heart (British Cardiac Society)
|
January 24, 2007
Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission
Anna Norhammar, Johan Lindbäck, Lars Rydén, et al.
European Journal of Preventive Cardiology
|
July 14, 2026
Obesity and Cardiovascular Outcomes After Myocardial Infarction - a nationwide SWEDEHEART analysis by diabetes status
Viveca Ritsinger, Bo Lagerqvist, Mattias Ekström, et al.
European Journal of Preventive Cardiology
|
February 6, 2020
Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry
Viveca Ritsinger, Thomas Nyström, Nawsad Saleh, et al.
Cardiovascular Diabetology
|
August 7, 2024
Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Viveca Ritsinger, Kamila Avander, Bo Lagerqvist, et al.
Journal of Periodontology
|
March 28, 2022
Association of peptidoglycan recognition protein 1 to post-myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study
Nilminie Rathnayake, Anders Gustafsson, Timo Sorsa, et al.
Diabetes & Vascular Disease Research
|
November 24, 2020
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
Viveca Ritsinger, Bo Lagerqvist, Pia Lundman, et al.
European Journal of Preventive Cardiology
|
May 17, 2022
Prognostic impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study
Stelios Karayiannides, Anna Norhammar, Lena Landstedt-Hallin, et al.
European Heart Journal
|
December 25, 2007
The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial
Linda G Mellbin, Klas Malmberg, Anna Norhammar, et al.
The Lancet. Diabetes & Endocrinology
|
May 17, 2014
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial
Viveca Ritsinger, Klas Malmberg, Anton Mårtensson, et al.
Page
of 11